Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents


INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

        This prospectus includes forward-looking statements. All statements other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations and financial position, strategy and plans, and our expectations for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "design," "intend," "expect," "could," "plan," "potential," "predict," "seek," "should," "would" or the negative version of these words and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, strategy, short- and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties, assumptions and other important factors, including those described in "Risk Factors." In light of these risks, uncertainties, assumptions and other factors, the forward-looking events and circumstances discussed in this prospectus may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

        Forward-looking statements include, but are not limited to, statements about:

    the timing and success of preclinical studies and clinical trials conducted by us and our development partners;
    the ability to obtain and maintain regulatory approval of our product candidates, and the labeling for any approved products;
    the scope, progress, expansion, and costs of developing and commercializing our current or future product candidates;
    the size and growth of the potential markets for our current or future product candidates and the ability to serve those markets;
    our expectations regarding our expenses and revenue, the sufficiency of our cash resources and needs for additional financing;
    the rate and degree of market acceptance of any of our current or future product candidates;
    our expectations regarding competition;
    our anticipated growth strategies;
    our ability to attract or retain key personnel;
    our ability to establish and maintain development partnerships;
    our expectations regarding federal, state and foreign regulatory requirements;
    regulatory developments in the United States and foreign countries;
    our ability to obtain and maintain intellectual property protection for our structure-based drug discovery platform and our product candidates;
    the anticipated trends and challenges in our business and the market in which we operate; and
    our use of proceeds from this offering and existing cash reserves.

        Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Any forward-looking statement made by us in this prospectus speaks only as of the date on which it is made. Except as required by law, we disclaim any duty to update any of these forward-looking statements after the date of this prospectus publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

        You should rely only on the information contained in this prospectus and any free writing prospectus prepared by us or on our behalf or to which we have referred you. You should read this prospectus and any such free writing prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement of which this prospectus is a part completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.

44